Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...ns, including the novel coronavirus, due to pre-existing lung damage. They are also at higher risk of developing complications from COVID-19.
more
DHS Working Papers No. 111 | Zimbabwe Working Papers No. 12
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...men characteristics corresponding to the needs of end-users.
more
Lessons from the STEP-TB Project.
Accessed November 2017.
Asylum and Migration Working Paper 1
Human Rights, Minimum Standards and Monitoring at the European and International Levels
DHS Working Papers No. 85
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Tuberculosis (TB) is the leading cause of illness and death among people living with HIV. TB can be cured.
DHS Analytical Studies No. 40
Copenhagen, Denmark, 24–25 August 2017
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380